NCT04120285

Brief Summary

We propose to carry out a treatment experiment in which we evaluate the extent to which randomizing primary care clinicians have access to remote internet-based Cognitive Behavior Therapy (eCBT) in rural West Virginia (WV) and Kentucky (KY) will help improve treatment of patients with Major Depressive Disorder (MDD). WV and KY are two of the most rural states in America and mental health treatment resources are low; especially in rural parts of the state.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,280

participants targeted

Target at P75+ for not_applicable major-depressive-disorder

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable major-depressive-disorder

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 9, 2019

Completed
1.3 years until next milestone

Study Start

First participant enrolled

January 9, 2021

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

5 years

First QC Date

May 31, 2019

Last Update Submit

March 23, 2026

Conditions

Keywords

DepressioneCBT

Outcome Measures

Primary Outcomes (1)

  • RDQ-7

    Investigators will assess all study patients remission from depression with the Remission from Depression Questionnaire (RDQ-7) via self-report assessments at 16 week follow-up. Investigators will monitor patients at 26, 39, and 52 weeks to evaluate the long-term maintenance of remission (or recurrence). The RDQ-7 is a measure with 41 items. Items are reported on a 3-point rating scale (0=not at all or rarely true; 1 = sometimes; 2 = often or almost always true). The total scale score ranges from 0-82. Participants with a total score below or equal to 27 are considered in remission. Higher total scores reflect greater pathology.

    16-Week Follow-up

Secondary Outcomes (3)

  • PROMIS Short Form v1.0 - Severity of Substance Use (past 30 days)

    16 week Follow-up

  • Compliance with Antidepressant Medication Treatment

    16 week Follow-up

  • SDM-Q-9

    52 week Follow-up

Study Arms (3)

Primary Care Treatment

NO INTERVENTION

The participant will receive treatment as usual as prescribed by the primary care physician for MDD.

Primary care treatment with eCBT

ACTIVE COMPARATOR

The participant will receive treatment as usual as prescribed by the primary care physician with the addition of eCBT for MDD.

Behavioral: remote internet-based cognitive behavior therapy (eCBT)

Primary care treatment with guided eCBT

ACTIVE COMPARATOR

The participant will receive treatment as usual as prescribed by the primary care physician with the addition of guided eCBT for MDD.

Behavioral: remote internet-based cognitive behavior therapy (eCBT)

Interventions

Provide access to online psychotherapy program to participants in rural WV areas at no expense to them.

Primary care treatment with eCBTPrimary care treatment with guided eCBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • seeking MDD treatment for the first time in the past 6 months (i.e., the beginning of a first or new course of treatment),
  • appropriate for outpatient treatment,
  • literate in English,
  • has access to a smart phone, home computer or willing to travel to access a computer
  • without hearing or vision or cognitive impairment that would interfere with research data collection
  • without history of either bipolar disorder or non-affective psychosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

University of Lousiville Health

Louisville, Kentucky, 40202, United States

Location

Upper Kanawha Clinic

Cedar Grove, West Virginia, 25039, United States

Location

Minnie Hamilton Health Systems

Glenville, West Virginia, 26351, United States

Location

Minnie Hamilton Health Systems

Grantsville, West Virginia, 26147, United States

Location

Harpers Ferry Family Medicine

Harpers Ferry, West Virginia, 25425, United States

Location

WVU Medicine

Morgantown, West Virginia, 26505, United States

Location

Wayne Medical Clinic

Wayne, West Virginia, 25570, United States

Location

Related Publications (1)

  • Bossarte RM, Kessler RC, Nierenberg AA, Chattopadhyay A, Cuijpers P, Enrique A, Foxworth PM, Gildea SM, Belnap BH, Haut MW, Law KB, Lewis WD, Liu H, Luedtke AR, Pigeon WR, Rhodes LA, Richards D, Rollman BL, Sampson NA, Stokes CM, Torous J, Webb TD, Zubizarreta JR. The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients. Trials. 2022 Jun 20;23(1):520. doi: 10.1186/s13063-022-06438-y.

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Robert Bossarte, PhD

    University of South Florida

    PRINCIPAL INVESTIGATOR
  • Ronald Kessler, PhD

    Harvard Medical School (HMS and HSDM)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participant recruiters will be blinded to the participant's intended treatment arm. Survey data collectors will be blinded to each participant's treatment arm.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: There are three treatment arms: 1) treatment as usual 2) treatment as usual with unguided eCBT and 3) treatment as usual with guided eCBT
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Psychiatry and Behavioral Neuroscience

Study Record Dates

First Submitted

May 31, 2019

First Posted

October 9, 2019

Study Start

January 9, 2021

Primary Completion

December 31, 2025

Study Completion

January 30, 2026

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations